Life Science INNvestor Reports
The life science industry holds diverse avenues of opportunity for investors, and INN has assembled a collection of free reports for those interested in jumping into this exciting space. With topics ranging from biotech to medical devices, our coverage can help you make the right decisions with your money.
From diagnostics to drug development, the genetics industry provides information that biotechnology, pharmaceutical and medical device companies need to continue making innovative products. INN has compiled an overview of each sector to help you make informed investment decisions. Access your report for FREE.
A report from BCC Research is estimating that the medical technology industry will cross revenue of almost US$797 billion by 2025, growing at a CAGR of 5.6 from 2020 to 2025. Driving that growth will be an increase in diseases, particularly cancer and diabetes, plus cardiovascular, neurological, orthopedic and respiratory diseases, which are on the rise due to age.
Market watchers agree that the psychedelic medicine sector is growing, and a variety of companies are set to enter this early stage public space. Read our FREE report to learn about the new and exciting psychedelics investing market!
The idea of investing in a psychedelic drug company may have sounded unlikely before 2020. But now investors are enjoying the dawn of a new alternative drug market that is trying to capitalize on the medical benefits of psychedelic substances. Lots of questions? Get our INNvestor Outlook Report Psychedelics Outlook – Plotting a New Course
The CRISPR-Cas9 technology is revolutionary new technology and changing what's possible with genetics. How do you profit from it? Download our Genetics INNvestor Report today!
COVID-19 continues to impact markets across the world. Here's an overview of INN's content on coronavirus investing. INN has prepared a series of articles to catch our investor audience up on the biggest developments related to the pandemic and how the markets are moving.